Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-07-26

FDA Approved: OLOPATADINE HYDROCHLORIDE OPHTHALMIC SOLUTION — Original Application (Bausch & Lomb Incorporated)

View source ↗

Summary

FDA approved an original Abbreviated New Drug Application for olopatadine hydrochloride ophthalmic solution by Bausch & Lomb for relief of itching associated wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OLOPATADINE HYDROCHLORIDE OPHTHALMIC SOLUTION (olopatadine hydrochloride ophthalmic solution)

Snippet

ORIG AP for OLOPATADINE HYDROCHLORIDE OPHTHALMIC SOLUTION (OLOPATADINE HYDROCHLORIDE OPHTHALMIC SOLUTION)